High Selectivity Of An Alpha-Conotoxin Lvia Analogue For Alpha 3 Beta 2 Nicotinic Acetylcholine Receptors Is Mediated By Beta 2 Functionally Important Residues

Xiaopeng Zhu,Si Pan,Manyu Xu,Lu Zhang,Jinfang Yu,Jinpeng Yu,Yong Wu,Yingxu Fan,Haonan Li,Igor E Kasheverov,Denis S Kudryavtsev,Victor I Tsetlin,Yi Xue,Dongting Zhangsun,Xinquan Wang,Sulan Luo

DOI: https://doi.org/10.1021/acs.jmedchem.0c00975

IF: 8.039

2020-01-01

Journal of Medicinal Chemistry

Abstract:The alpha 3 beta 2 and alpha 3 beta 4 nicotinic acetylcholine receptors (nAChRs) are widely expressed in the central and peripheral nervous systems, playing critical roles in various physiological processes and in such pathologies as addiction to nicotine and other drugs of abuse. alpha-Conotoxin LvIA, which we previously isolated from Conus lividus, modestly discriminates alpha 3 beta 2 and alpha 3 beta 4 rat nAChRs exhibiting a similar to 17-fold tighter binding to the former. Here, alanine scanning resulted in two more selective analogues [N9A]LvIA and [D11A]LvIA, the former having a >2000-fold higher selectivity for alpha 3 beta 2. The determined crystal structures of [N9A]LvIA and [D11A]LvIA bound to the acetylcholine-binding protein (AChBP) were followed by homologous modeling of the complexes with the alpha 3 beta 2 and alpha 3 beta 4 nAChRs and by receptor mutagenesis, which revealed Phe106, Ser108, Ser113, and Ser168 residues in the beta 2 subunit as essential for LvIA binding. These results may be useful for the design of novel compounds of therapeutic potential targeting alpha 3 beta 2 nAChRs.